VialsRx
- 503A
“We partner with a trusted, US-based compounding pharmacy — VialsRx — that operate in full compliance with FDA guidelines and USP 797 sterile compounding standards.”
Curve Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10
Best for: knowing which pharmacy fills the vial: it names VialsRx
7.5
★★★★☆3.8/5
Curve's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
$175/mo
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
See plans →See plans at Curve →
Compare top-rated alternatives ↓Prices checked August 2026
Commit longer and pay less: semaglutide spans $99-$175/mo and tirzepatide $135-$225/mo, dose making no difference, and each tier absorbs expedited shipping at no cost, the drug, the prescription and the consultation, with membership charged to nobody. Try Curve LLC leans on providers from Beluga Health, licensed everywhere in the 50 states, and on a 503A compounder in the US, VialsRx. A questionnaire replaces the video visit, reviewed by a provider within 24 hours. HSA/FSA is welcome; insurance isn't accepted. LegitScript-certified.
By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
GLP-1 from $175/moFlat across dosesIncludes medication + consultAll 50 statesPharmacy namedNo FDA warning letters found
Is Curve legit?
Yes. Curve is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 7.5/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Curve promo or coupon code?
We know of no promo or coupon code for Curve. Its listed price is $175 a month. Coupon sites advertising "Curve discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Curve compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Curve
9.4/ 10
Verified partnerTrimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
★★★★★4.7/5
Editorial score · methodology
$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Trimi Health review →★★★☆☆3.2/5
Editorial score · methodology
$149/mo
CompoundedSemaglutideTirzepatideOrforglipronGHK-Cu
Get StartedRead full ShedRx review →★★★★★4.5/5
Editorial score · methodology
$99/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full bmiMD review →Curve at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $175/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Consult · Medication · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How Curve scores
Six columns, each one computed from something Curve has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
5.8/10$225/month is 10% below the $250 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
5.0/10Where this seller first shows a price is not known, so sign-up is held at the midpoint.
Trust & Safety15%
7.5/10It names the pharmacy that fills its prescriptions. There is no confirmed price before the medical intake. It lists the states it serves.
Accessibility10%
10.0/10Serves 50 of 50 states.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
6weighted dimensions
588sellers compared
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Curve
Last checked August 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Confirmed which compounding pharmacy fills the order, and its accreditation
- Checked FDA warning letters for Curve
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
Cancelling Curve
Taken from the terms Curve publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- Not published by the seller
GLP-1 medications Curve offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
MonthlyCompounded
$175/mo
semaglutide
Month-to-month; drops to $145/mo (quarterly), $120/mo (6-month), or $99/mo on annual prepay. All doses priced the same.
MonthlyCompounded
$225/mo
tirzepatide
Month-to-month; drops to $199/mo (quarterly), $175/mo (6-month), or $135/mo on annual prepay. All doses priced the same.
Check the price yourself before you pay
Every figure here was read off Curve's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
Curve compounding-pharmacy partners
Each partner below is a 503A or 503B pharmacy that Curve routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
In its favor
- Semaglutide costs $175 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $225 a month, 10% below the $250 median for compounded tirzepatide across the sellers we compare
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- Names VialsRx as the pharmacy that fills its prescriptions, which most sellers do not
- We found no FDA warning letters issued to Curve
Against it
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Curve charges
The standing price at Curve is $175/month, unchanged as the dose goes up. Flat dose pricing matters more than it sounds: on a tiered plan the bill grows with the dose, so the figure that got you to sign up is not the one you end up paying.
- Compounded semaglutide: $175/month
- Compounded tirzepatide: $225/month
For compounded tirzepatide, the median across the sellers we compare is $250/month, so Curve's $225 is genuinely below the middle, not just advertised that way.
DudeMeds, at about $175/month, is the closest like-for-like alternative we review.
What Curve dispenses
Curve prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality.
Safety and disclosure
Curve tells you that it treats patients in all 50 states and the pharmacy that fills its prescriptions. We found no FDA warning letters issued to Curve. Because the medication is compounded, the named pharmacy is the detail that matters most: its license is the one you can look up. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to pay for it. Curve is cash-pay and does not bill insurance.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
- you need access wherever you live
Our read
Curve competes on price without an obvious sacrifice elsewhere: $225/month for compounded tirzepatide, no FDA warning letters, and wide state coverage.
The Bottom Line
Curve's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Score: 7.5/10Best for: knowing which pharmacy fills the vial: it names VialsRxFrom: $175/mo
Before you pay Curve
Starting at $175 a month. Check today's price, then start the intake.
Where Curve is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare Curve head to head
The sellers closest to Curve on medication and price.
Frequently Asked Questions
Commit longer and pay less: semaglutide spans $99-$175/mo and tirzepatide $135-$225/mo, dose making no difference, and each tier absorbs expedited shipping at no cost, the drug, the prescription and the consultation, with membership charged to nobody. Try Curve LLC leans on providers from Beluga Health, licensed everywhere in the 50 states, and on a 503A compounder in the US, VialsRx. A questionnaire replaces the video visit, reviewed by a provider within 24 hours. HSA/FSA is welcome; insurance isn't accepted. LegitScript-certified. We rate it 7.5/10 overall.
Curve starts at $175 a month. That number holds across doses, so titrating up does not move the bill. The pricing table above lists every tier.
Curve says it treats patients in all 50 states.
Curve sells semaglutide (sold as Wegovy and Ozempic) and tirzepatide (sold as Zepbound and Mounjaro). Every dose it lists is compounded.
Curve lists compounded GLP-1s only. A licensed compounding pharmacy prepares them: same active ingredient as the brand drug, lower cash price, and no FDA approval of the finished product. That last part is the one readers underestimate, and the review above says why.
No. Curve is cash-pay and does not bill insurance. It also takes FSA and HSA cards. Plan on paying the listed price yourself.
Curve says the price covers medication, the clinician visit and shipping. The strip near the top of this review shows what is included and what is not.
You fill in an online intake, a licensed clinician decides whether a GLP-1 is appropriate, and if the answer is yes the medication ships to you. Curve runs that whole sequence on its own site.
We found no FDA warning letters issued to Curve. Before you buy, weigh these: Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality. None of them rules Curve out, but each is worth settling before you pay.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Curve review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Curve's current pricing
Plans start at $175 a month. Whether you qualify is a clinician's decision, made after your intake.
Not sold on Curve?
Vetted alternatives